In 2014, Greife and colleagues [82] examined the canonical NOTCH1 signalling pathway and found it to be downregulated, along with its ligand DLL1, throughout all stages and histological grades of bladder cancer, with the lowest levels observed in high-stage tumours. The gene discussed is NOTCH1; the disease is urinary bladder cancer.